Healthcare provider profile · identity verified

William Jacobson, MD

Family Practice · WHITE PLAINS, NY · NPI 1801803556

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	516	143
Amlodipine Besylate	Amlodipine Besylate	383	101
Levothyroxine Sodium	Levothyroxine Sodium	283	60
Escitalopram Oxalate	Escitalopram Oxalate	247	35
Eliquis	Apixaban	181	55
Furosemide	Furosemide	177	66
Pantoprazole Sodium	Pantoprazole Sodium	172	75
Metoprolol Succinate	Metoprolol Succinate	171	65
Metoprolol Tartrate	Metoprolol Tartrate	169	26
Rosuvastatin Calcium	Rosuvastatin Calcium	166	54
Mirtazapine	Mirtazapine	145	26
Tamsulosin Hcl	Tamsulosin Hcl	142	36
Donepezil Hcl	Donepezil Hcl	139	26
Famotidine	Famotidine	133	31
Lisinopril	Lisinopril	131	45
Losartan Potassium	Losartan Potassium	129	44
Metformin Hcl	Metformin Hcl	123	26
Sertraline Hcl	Sertraline Hcl	120	36
Gabapentin	Gabapentin	115	43
Memantine Hcl	Memantine Hcl	114	22
Finasteride	Finasteride	89	13
Carvedilol	Carvedilol	86	20
Simvastatin	Simvastatin	81	21
Trazodone Hcl	Trazodone Hcl	81	16
Fluoxetine Hcl	Fluoxetine Hcl	80	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	79	21
Omeprazole	Omeprazole	78	25
Memantine Hcl Er	Memantine Hcl	76	suppressed
Allopurinol	Allopurinol	75	25
Hydrochlorothiazide	Hydrochlorothiazide	75	26
Potassium Chloride	Potassium Chloride	73	30
Glipizide	Glipizide	70	18
Zolpidem Tartrate	Zolpidem Tartrate	69	13
Amiodarone Hcl	Amiodarone Hcl	67	13
Shingrix	Varicella-Zoster Ge/As01b/Pf	63	51
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	59	59
Clopidogrel	Clopidogrel Bisulfate	53	25
Torsemide	Torsemide	49	suppressed
Alprazolam	Alprazolam	47	15
Carbidopa-Levodopa	Carbidopa/Levodopa	47	suppressed
Citalopram Hbr	Citalopram Hydrobromide	43	suppressed
Ezetimibe	Ezetimibe	42	11
Xarelto	Rivaroxaban	41	12
Rivastigmine	Rivastigmine Tartrate	39	suppressed
Divalproex Sodium	Divalproex Sodium	38	suppressed
Entresto	Sacubitril/Valsartan	36	suppressed
Olanzapine	Olanzapine	34	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	33	33
Buspirone Hcl	Buspirone Hcl	33	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	33	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	30	suppressed
Azithromycin	Azithromycin	30	25
Diltiazem Hcl	Diltiazem Hcl	30	suppressed
Pravastatin Sodium	Pravastatin Sodium	30	suppressed
Glipizide Er	Glipizide	29	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	29	suppressed
Nifedipine Er	Nifedipine	28	suppressed
Fluticasone Propionate	Fluticasone Propionate	27	14
Latanoprost	Latanoprost	27	suppressed
Spironolactone	Spironolactone	27	16
Warfarin Sodium	Warfarin Sodium	27	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	26	suppressed
Duloxetine Hcl	Duloxetine Hcl	25	11
Meloxicam	Meloxicam	25	14
Novolog Flexpen	Insulin Aspart	25	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	24	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	23	15
Bumetanide	Bumetanide	23	suppressed
Divalproex Sodium Er	Divalproex Sodium	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	suppressed
Megestrol Acetate	Megestrol Acetate	22	suppressed
Prednisone	Prednisone	22	13
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	18
Atenolol	Atenolol	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	14
Gemtesa	Vibegron	19	suppressed
Cyproheptadine Hcl	Cyproheptadine Hcl	18	suppressed
Ongentys	Opicapone	18	suppressed
Rytary	Carbidopa/Levodopa	18	suppressed
Digoxin	Digoxin	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	17	suppressed
Metformin Hcl Er	Metformin Hcl	17	suppressed
Montelukast Sodium	Montelukast Sodium	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Clonazepam	Clonazepam	16	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Timolol Maleate	Timolol Maleate	16	suppressed
Tramadol Hcl	Tramadol Hcl	16	13
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	11
Lorazepam	Lorazepam	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Baclofen	Baclofen	13	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Morphine Sulfate	Morphine Sulfate	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Galantamine Er	Galantamine Hbr	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Jardiance	Empagliflozin	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error